Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enovix Corporation filings document the regulatory disclosures of an advanced lithium-ion battery manufacturer commercializing silicon-anode battery architectures. Recent Form 8-K reports cover operating results, Regulation FD updates, customer qualification and commercial updates, executive changes, manufacturing-scale communications and board-authorized capital actions.
The filing record also includes capital-structure disclosures related to convertible senior notes, warrants to purchase common stock, share repurchase plans and common-stock matters. Proxy materials document board elections, executive compensation, equity awards and shareholder voting items, while current reports provide formal exhibits for press releases and material agreements.
Enovix Corp officer Kristina Truong reported a routine equity compensation event. On December 10, 2025, 252 shares of Enovix common stock were withheld at a price of $9.13 per share to satisfy tax withholding obligations tied to the vesting of restricted stock units.
After this transaction, she beneficially owns 200,057 shares of Enovix common stock. This includes 154,998 shares issuable upon the vesting and settlement of RSUs and 4,978 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 21, 2025, she received 3,833 shares of common stock through a fully vested restricted stock unit (RSU) award, serving as her bonus for the quarter ended September 28, 2025. Each RSU converts into one share of Enovix common stock.
To cover tax withholding related to this RSU award, 2,026 shares of common stock were withheld and disposed of at a price of $7.47 per share. After these transactions, Truong beneficially owned 200,309 shares of Enovix common stock, including shares issuable from outstanding RSUs and vested performance RSUs scheduled for release in March 2026 and March 2027.
Enovix Corporation (ENVX) reported insider equity activity for its Chief Legal Officer, Arthi Chakravarthy. On November 21, 2025, she received 4,960 shares of common stock at a price of $0, issued upon the receipt of fully vested restricted stock units (RSUs) earned as bonus for the quarter ended September 28, 2025, with each RSU equal to one share.
To cover tax withholding on RSU vesting, 2,622 shares were withheld on November 21, 2025 at $7.47 per share and 2,217 shares were withheld on November 24, 2025 at $7.58 per share. Following these transactions, Chakravarthy beneficially owned 424,156 shares, including 303,276 shares issuable from RSUs and 20,786 vested performance RSUs scheduled for releases in March 2026 and March 2027.
Enovix Corporation (ENVX) Chief Operating Officer Ajay Marathe reported equity award activity in company stock. On November 21, 2025, he received 6,035 shares of common stock at $0, issued upon the vesting of restricted stock units that represented his bonus for the quarter ended September 28, 2025.
On the same date, 3,190 shares were withheld at a price of $7.47 to cover tax obligations tied to the RSU vesting. After these transactions, Marathe beneficially owned 989,363 shares of Enovix common stock, including large amounts issuable from previously granted RSUs and vested performance RSUs scheduled for release in 2026 and 2027.
Enovix Corp (ENVX) reported a routine insider equity transaction by its Chief Financial Officer. On November 21, 2025, the reporting person received 5,729 shares of common stock through a fully vested restricted stock unit (RSU) award that served as a bonus for the quarter ended September 28, 2025, at a stated price of $0 per share. On the same date, 3,028 shares of common stock were withheld at $7.47 per share to cover tax obligations related to this RSU vesting. After these transactions, the reporting person beneficially owned 753,690 shares of Enovix common stock, including 748,752 shares issuable upon settlement of previously granted RSUs.
Enovix Corporation (ENVX) reported insider equity activity by its President and CEO, who is also a director. On November 21, 2025, the executive received 9,427 shares of common stock at $0, issued upon the vesting of restricted stock units (RSUs) that represent bonus awards for the quarter ended September 28, 2025. On the same date, 4,983 shares were withheld at a price of $7.47 to cover tax obligations tied to this RSU vesting.
Following these transactions, the executive beneficially owned 2,298,829 shares of Enovix common stock on a direct basis. This total includes 1,674,293 shares underlying RSUs and 95,551 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each RSU or PRSU represents the right to receive one share of common stock.
Enovix Corporation (ENVX) reported an insider stock transaction by its President, CEO and Director, Raj Talluri. On November 20, 2025, he donated 925 shares of Enovix common stock to two charitable organizations at a reported price of $0, reflecting a gift rather than a sale. After this donation, he beneficially owned 2,294,385 shares of Enovix common stock. This total includes 1,674,293 shares issuable upon settlement of restricted stock units (RSUs) and 95,551 vested performance RSUs. For the performance RSUs, 50% are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each PRSU representing the right to receive one share upon settlement.
Enovix Corporation (ENVX) president and CEO Raj Talluri, who also serves as a director, reported an automatic share withholding related to equity compensation. On November 18, 2025, 17,617 shares of Enovix common stock were withheld at a price of $7.50 per share to cover tax obligations triggered by the vesting of restricted stock units (RSUs). These are not open-market sales but shares retained by the company for taxes.
Following this transaction, Talluri beneficially owns 2,295,310 Enovix shares in total. This amount includes 1,674,293 shares issuable upon settlement of RSUs and 95,551 shares of vested performance RSUs (PRSUs), with half of the PRSUs scheduled to be released on March 2, 2026 and the remaining half on March 1, 2027. Each RSU and PRSU represents a right to receive one share of Enovix common stock.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported an automatic share withholding related to equity compensation. On November 14, 2025, 7,338 shares of Enovix common stock were withheld at $8.03 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Marathe beneficially owned 986,518 shares, including 743,818 shares tied to unvested RSUs and 33,170 vested performance RSUs (PRSUs). Half of these PRSUs are scheduled for release on March 2, 2026, with the remaining half on March 1, 2027, each representing a right to receive one share upon settlement.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 13, 2025, 1,013 shares of common stock were withheld at a price of $8.08 to cover tax obligations related to the vesting of restricted stock units (RSUs). After this transaction, the reporting person beneficially owned 198,502 shares of common stock.
This total includes 155,474 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). For these PRSUs, 50% of the shares are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each RSU or PRSU representing the right to receive one share of Enovix common stock.